MIMS drug shortages tracker updated with latest supply issues

Supply issues have been reported in the past week for products including the smoking cessation treatment Champix (varenicline) and Dalacin (clindamycin) vaginal cream.

The MIMS drug shortages tracker currently lists 110 products facing supply issues. | GETTY IMAGES
The MIMS drug shortages tracker currently lists 110 products facing supply issues. | GETTY IMAGES

All presentations of Champix are currently unavailable and it is not known when they will be back in stock. Resupply of Dalacin cream is expected in early September.

Further information

View MIMS shortages tracker

Pharmacists have also reported shortages of loratadine and cetirizine oral solutions. Pinewood have confirmed supply issues with their products until later in June (for loratadine 5mg/5ml oral solution) or July (for cetirizine 1mg/ml oral solution) and GSK Consumer say Piritize Allergy (cetirizine) syrup is out of stock until mid-July. 

The MIMS tracker currently lists a total of 110 products facing supply issues. Other products recently added to the tracker are:

  • DHC Continus (dihydrocodeine) 60mg sustained-release tablets - limited supplies until late June
  • Ipinnia XL (ropinirole) 8mg tablets - due back in stock in September
  • Ventolin (salbutamol) syrup - due back in stock at the end of June
  • Xyloproct (lidocaine/hydrocortisone) - resupply expected w/c 19th July

Shortages have now been resolved for Abstral (fentanyl) 800 microgram sublingual tablets, CoAprovel (irbesartan/hydrochlorothiazide), Dermovate (clobetasol) cream, Estradot (estradiol) 75 microgram patches, Diprosalic (betamethasone/salicylic acid) scalp application and Rifinah (rifampicin/isoniazid).

All healthcare professionals have limited free access to the shortages tracker. A MIMS subscription provides unrestricted access to the tracker and the opportunity to receive a weekly shortages bulletin, along with unlimited access to all other MIMS prescribing resources.

Want news like this straight to your inbox?
Sign up for our bulletins

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Already registered?
Sign in

More from MIMS

An elderly woman with one arm in a plaster cast sits resting both hands on her walker

Doctors urge NICE to reverse decision on new osteoporosis drug

More than NHS 100 clinicians have called on NICE to...

Drug shortages - live tracker

Use our constantly updated shortages tracker to check...

Image of both strengths of Seffalair Spiromax inhaler side by side.

New salmeterol/fluticasone dry powder inhaler for asthma

Seffalair Spiromax is the sixth dry powder salmeterol/fluticasone...

An older man in a blue shirt and beige trousers leans forward on a sofa rubbing his painful lower back. Promoted

Established muscle relaxant offers new approach to managing back pain

Sponsored by Mibe Pharma

A muscle relaxant that has been used for decades outside the UK may provide an alternative to current treatments for low back pain, explains Dr Sunny Nayee, consultant in anaesthesia and pain medicine at Imperial College NHS Healthcare Trust.

Sponsored by Mibe Pharma UK Ltd. UK/MYO/21/044; December 2021.

Click here to view prescribing information for Myopridin® (pridinol mesilate)